MedTrace Logo

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

NCT04792281 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2024-11-22

No results posted yet for this study

Summary

The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.

Conditions

  • Infective Endocarditis
  • Native Valve Endocarditis

Sponsors & Collaborators

  • Montreal Heart Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792281 on ClinicalTrials.gov